Today's After-Hours Movers

Tesla (NASDAQ: TSLA) 11.2% HIGHER; reported Q4 EPS of $2.14, $0.42 better than the analyst estimate of $1.72. Revenue for the quarter came in at $7.38 billion versus the consensus estimate of $7.02 billion. Model Y production ramp started in January 2020, ahead of schedule; Record vehicle deliveries of 112,095 in Q4.

ServiceNow (NYSE: NOW) 8.5% HIGHER; reported Q4 EPS of $0.96, $0.09 better than the analyst estimate of $0.87. Revenue for the quarter came in at $951.8 million versus the consensus estimate of $941.17 million.

Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) 8.3% LOWER; intends to offer its securities in an underwritten public offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Sunrun Inc. (NASDAQ: RUN) 7.7% HIGHER; will replace Darling Ingredients in the S&P SmallCap 600

Qorvo (NASDAQ: QRVO) 7.5% HIGHER; reported Q3 EPS of $1.86, $0.18 better than the analyst estimate of $1.68. Revenue for the quarter came in at $869 million versus the consensus estimate of $852.04 million. Qorvo sees Q4 2020 EPS of $1.55-$1.15. Qorvo sees Q4 2020 revenue of $800-840 million, versus the consensus of $727.8 million.

Facebook (NASDAQ: FB) 7.3% LOWER; reported Q4 EPS of $2.56, $0.03 better than the analyst estimate of $2.53. Revenue for the quarter came in at $21.08 billion versus the consensus estimate of $20.89 billion. Facebook daily active users (DAUs) – DAUs were 1.66 billion on average for December 2019, an increase of 9% year-over-year.

Cirrus Logic, Inc. (NASDAQ: CRUS) 6.7% HIGHER; reported Q3 EPS of $1.41, $0.28 better than the analyst estimate of $1.13. Revenue for the quarter came in at $374.7 million versus the consensus estimate of $346.49 million. Cirrus Logic, Inc. sees Q4 2020 revenue of $250-290 million, versus the consensus of $245.68 million.

Lam Research (NASDAQ: LRCX) 6.6% HIGHER; reported Q2 EPS of $4.01, $0.16 better than the analyst estimate of $3.85. Revenue for the quarter came in at $2.58 billion versus the consensus estimate of $2.51 billion. Lam Research sees Q3 2020 EPS of $4.55 at mid-point, versus the consensus of $4.00. Lam Research sees Q3 2020 revenue of $2.8 billion at mid-point, versus the consensus of $2.58 billion.

Aspen Technology (NASDAQ: AZPN) 6% LOWER; reported Q2 EPS of $0.66, $0.14 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $124.7 million versus the consensus estimate of $135.46 million. Aspen Technology sees FY2020 EPS of $3.43-$3.84, versus the consensus of $3.79. Aspen Technology sees FY2020 revenue of $575-615 million, versus the consensus of $602.43 million.

DBV Technologies (Nasdaq: DBVT) 5.1% LOWER; announced its intention to launch, subject to market conditions, a global offering of new ordinary shares, which may be in the form of American Depositary Shares (ADSs), in an aggregate amount of $125.0 million.

Applied Materials, Inc. (NASDAQ: AMAT) 4.7% HIGHER; gains on Lam Research's results.

Dolby Laboratories (NYSE: DLB) 4.6% HIGHER; reported Q1 EPS of $0.64, $0.15 better than the analyst estimate of $0.49. Revenue for the quarter came in at $291.9 million versus the consensus estimate of $285.81 million. Dolby Laboratories sees Q2 2020 EPS of $1.15-$1.21, versus the consensus of $1.16. Dolby Laboratories sees Q2 2020 revenue of $370-390 billion, versus the consensus of $379.15 billion. Dolby Laboratories sees FY2020 EPS of $3.40-$3.50, versus the consensus of $3.45. Dolby Laboratories sees FY2020 revenue of $1.3-1.35 billion, versus the consensus of $1.33 billion.

Intevac. (NASDAQ: IVAC) 4.4% HIGHER; reported Q4 EPS of $0.08, $0.12 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $31.6 million versus the consensus estimate of $34.4 million.

Align Technology (NASDAQ: ALGN) 4% LOWER; reported Q4 EPS of $1.53, $0.13 better than the analyst estimate of $1.40. Revenue for the quarter came in at $649.8 million versus the consensus estimate of $646.51 million. Sees Q1 revenue range of $615.0 million to $630.0 million and Non-GAAP diluted EPS in the range of $1.19 to $1.28, versus consensus of $1.44 on revenue of $657.3 million.

KLA Corporation (NASDAQ: KLAC) 3.1% HIGHER; gains on Lam Research's results.

Hologic (NASDAQ: HOLX) 3% LOWER; reported Q1 EPS of $0.61, in-line with the analyst estimate of $0.61. Revenue for the quarter came in at $850.5 million versus the consensus estimate of $839.82 million. Hologic sees Q2 2020 EPS of $0.61-$0.63, versus the consensus of $0.63. Hologic sees Q2 2020 revenue of $770-780 million, versus the consensus of $811.39 million. Hologic sees FY2020 EPS of $2.63-$2.67, versus the consensus of $2.61. Hologic sees FY2020 revenue of $3.238-3.268 billion, versus the consensus of $3.32 billion.